Geert W J Frederix - JoVE Visualize

Showing results (51-60 of 63) with videos related to

Pageof 7

Sort By:

Cytotherapy|May 17, 2020

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costingsRenske M T Ten Ham, Anke M Hövels, Jarno Hoekman, et al.

European Journal of Pediatrics|March 30, 2023

Rapid exome sequencing as a first-tier test in neonates with suspected genetic disorder: results of a prospective multicenter clinical utility study in the NetherlandsRichelle A C M Olde Keizer, Abderrahim Marouane, Wilhelmina S Kerstjens-Frederikse, et al.

Annals of Surgery|October 3, 2024

Paravertebral Versus EPidural Analgesia in Minimally Invasive Esophageal ResectioN (PEPMEN): A Randomized Controlled Multicenter TrialMinke L Feenstra, Cezanne D Kooij, Wietse J Eshuis, et al.

JAMA Surgery|December 28, 2022

Cost-effectiveness of Laparoscopic vs Open Gastrectomy for Gastric Cancer: An Economic Evaluation Alongside a Randomized Clinical TrialArjen van der Veen, Miriam P van der Meulen, Maarten F J Seesing, et al.

Frontiers in Immunology|January 7, 2022

Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic CentersKim Elsink, Manon M H Huibers, Iris H I M Hollink, et al.

Surgical Endoscopy|March 4, 2026

Cost-effectiveness of Paravertebral versus EPidural analgesia in Minimally invasive Esophageal resectioN (PEPMEN): an economic evaluation alongside a randomized clinical trialCezanne D Kooij, Kirsten Opmeer, Minke L Feenstra, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2025

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled TrialAniek E M Schouten, Anouk E Hiensch, Geert W J Frederix, et al.

Trials|September 25, 2023

Endoscopic ultrasonography-guided gastroenterostomy versus surgical gastrojejunostomy for palliation of malignant gastric outlet obstruction (ENDURO): study protocol for a randomized controlled trialJanine B Kastelijn, Yorick L van de Pavert, Marc G Besselink, et al.

The Lancet. Oncology|October 24, 2018

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysisLinda M Henricks, Carin A T C Lunenburg, Femke M de Man, et al.

JAMA|September 8, 2025

Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical TrialAnne W T van der Wel, Chryselle M C Frank, Rebekka Bout-Rebel, et al.

Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:

Pageof 7

Cytotherapy|May 17, 2020

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costingsRenske M T Ten Ham, Anke M Hövels, Jarno Hoekman, et al.

European Journal of Pediatrics|March 30, 2023

Rapid exome sequencing as a first-tier test in neonates with suspected genetic disorder: results of a prospective multicenter clinical utility study in the NetherlandsRichelle A C M Olde Keizer, Abderrahim Marouane, Wilhelmina S Kerstjens-Frederikse, et al.

Annals of Surgery|October 3, 2024

Paravertebral Versus EPidural Analgesia in Minimally Invasive Esophageal ResectioN (PEPMEN): A Randomized Controlled Multicenter TrialMinke L Feenstra, Cezanne D Kooij, Wietse J Eshuis, et al.

JAMA Surgery|December 28, 2022

Cost-effectiveness of Laparoscopic vs Open Gastrectomy for Gastric Cancer: An Economic Evaluation Alongside a Randomized Clinical TrialArjen van der Veen, Miriam P van der Meulen, Maarten F J Seesing, et al.

Frontiers in Immunology|January 7, 2022

Implementation of Early Next-Generation Sequencing for Inborn Errors of Immunity: A Prospective Observational Cohort Study of Diagnostic Yield and Clinical Implications in Dutch Genome Diagnostic CentersKim Elsink, Manon M H Huibers, Iris H I M Hollink, et al.

Surgical Endoscopy|March 4, 2026

Cost-effectiveness of Paravertebral versus EPidural analgesia in Minimally invasive Esophageal resectioN (PEPMEN): an economic evaluation alongside a randomized clinical trialCezanne D Kooij, Kirsten Opmeer, Minke L Feenstra, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2025

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled TrialAniek E M Schouten, Anouk E Hiensch, Geert W J Frederix, et al.

Trials|September 25, 2023

Endoscopic ultrasonography-guided gastroenterostomy versus surgical gastrojejunostomy for palliation of malignant gastric outlet obstruction (ENDURO): study protocol for a randomized controlled trialJanine B Kastelijn, Yorick L van de Pavert, Marc G Besselink, et al.

The Lancet. Oncology|October 24, 2018

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysisLinda M Henricks, Carin A T C Lunenburg, Femke M de Man, et al.

JAMA|September 8, 2025

Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical TrialAnne W T van der Wel, Chryselle M C Frank, Rebekka Bout-Rebel, et al.

Pageof 7